U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 02:27:53 GMT 2023
Edited
by admin
on Sat Dec 16 02:27:53 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
31YO63LBSN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NIVOLUMAB
DASH   INN   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
OPDUALAG COMPONENT NIVOLUMAB
Brand Name English
OPDIVO
Brand Name English
BMS-986213 COMPONENT NIVOLUMAB
Common Name English
MDX-1106
Code English
NIVOLUMAB COMPONENT OF OPDUALAG
Brand Name English
BMS-936558
Code English
NIVOLUMAB [USAN]
Common Name English
NIVOLUMAB [JAN]
Common Name English
NIVOLUMAB [MI]
Common Name English
nivolumab [INN]
Common Name English
NIVOLUMAB [PURPLE BOOK CDER]
Common Name English
NIVOLUMAB [VANDF]
Common Name English
MDX1106
Code English
Nivolumab [WHO-DD]
Common Name English
BMS-986298
Code English
ONO-4538
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 591617
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
NDF-RT N0000191260
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
EMA ASSESSMENT REPORTS OPDIVO (AUTHORIZED: MELANOMA)
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 670918
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 595817
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
NCI_THESAURUS C128037
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
EMA ASSESSMENT REPORTS NIVOLUMAB BMS( WITHDRAWN: CARCINOMA, NON-SMALL-CELL LUNG)
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 442614
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 595017
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 469615
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 641718
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 545016
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 445014
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 387612
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 489915
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 491415
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 595917
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
WHO-ATC L01XC17
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
FDA ORPHAN DRUG 531016
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
Code System Code Type Description
MESH
C551361
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
FDA UNII
31YO63LBSN
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
INN
9623
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
MERCK INDEX
m11824
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
SMS_ID
100000145087
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
DRUG CENTRAL
4923
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
RXCUI
1597876
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY RxNorm
CAS
946414-94-4
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
EVMPD
SUB122750
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
IUPHAR
7335
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
NDF-RT
N0000191259
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY Programmed Death Receptor-1-directed Antibody Interactions [MoA]
DAILYMED
31YO63LBSN
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
DRUG BANK
DB09035
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
ChEMBL
CHEMBL2108738
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
USAN
YY-151
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
WIKIPEDIA
Nivolumab
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
LACTMED
Nivolumab
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
NCI_THESAURUS
C68814
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
HSDB
8256
Created by admin on Sat Dec 16 02:27:53 GMT 2023 , Edited by admin on Sat Dec 16 02:27:53 GMT 2023
PRIMARY
From To
1_22 1_96
1_140 1_196
1_254 1_314
1_360 1_418
2_22 2_96
2_140 2_196
2_254 2_314
2_360 2_418
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_127 3_214
2_127 4_214
1_219 2_219
1_222 2_222
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_290
N 2_290
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL